Table 7.
Anti-virus activity of isoflavones
| Isoflavone | Virus | Mechanism of action | Dose/concentration | References |
|---|---|---|---|---|
| Genistein | Avian leucosis virus | Inhibits the late phase of ALV-J replicative cycle | 12.5–100 μM | Qian et al. [77] |
| Porcine reproductive and respiratory syndrome virus (PRRSV) | Activation of adaptive immune system pathways | Smith et al. [78] | ||
| Genistein | African swine fever virus | Disrupts viral DNA replication, blocking the transcription of late viral genes as well as the synthesis of late viral proteins, reducing viral progeny | IC50 = 13 μM, | Arabyan et al. [79] |
| Genistein | rotavirus | Inhibits rotavirus replication and upregulates AQP4 expression | 80 μM | Huang et al. [80] |
| Genistein | Herpes simplex virus | Inhibits virus replication | 40 μM | Argenta et al. [81] |
| KIN 101 | hepatitis C virus (HCV) and influenza virus | Activates the ISG54 promoter mediated nuclear translocation of IRF-3 | IC50 = 0.2 μM | Bedard et al. [82] |
| Deguelin | Human cytomegalovirus (HCMV) | Suppresses the production of the infectious virus; inhibits the lytic cycle | 250 nM | Nukui et al. [83] |
| HIV-1 | Inhibits HIV-1 entry into cell lines, primary human CD4+ T lymphocytes, and macrophages | IC50 = 81.6 ± 4.3 μM | Mediouni et al. [84] | |
| Daidzein | Dengue virus type-2 | Inhibits virus replication | IC50 = 142.6 μg/mL | Zandi et al. [43] |